SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-005259
Filing Date
2023-02-27
Accepted
2023-02-27 16:38:47
Documents
90
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcrx-20221231.htm   iXBRL 10-K 2401523
2 EX-10.25 formofnoticeofgrantofrsuan.htm EX-10.25 48338
3 EX-21 exhibit21-subsidiaries.htm EX-21 7764
4 EX-23 exhibit23-fy22form10xkcons.htm EX-23 6671
5 EX-31.1 bcrx-20221231xex311.htm EX-31.1 9835
6 EX-31.2 bcrx-20221231xex312.htm EX-31.2 9832
7 EX-32.1 bcrx-20221231xex321.htm EX-32.1 6105
8 EX-32.2 bcrx-20221231xex322.htm EX-32.2 5601
14 GRAPHIC bcrx-20221231_g1.jpg GRAPHIC 110546
  Complete submission text file 0001628280-23-005259.txt   10901344

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20221231.xsd EX-101.SCH 81334
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20221231_cal.xml EX-101.CAL 85089
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20221231_def.xml EX-101.DEF 342335
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20221231_lab.xml EX-101.LAB 884332
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20221231_pre.xml EX-101.PRE 543879
84 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20221231_htm.xml XML 1805501
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 23675662
SIC: 2836 Biological Products, (No Diagnostic Substances)